Initial public offering of Alligator Bioscience AB (SE) on Nasdaq Stockholm – SEK 483 million Healthcare Initial public offering of Alligator Bioscience AB (SE) on Nasdaq Stockholm – SEK 483 million
Placing of shares in Nordax Group AB (SE) — SEK 490 million FIG Placing of shares in Nordax Group AB (SE) — SEK 490 million
Directed and rights issue in Sagax AB (SE) — SEK 484 million Real Estate Directed and rights issue in Sagax AB (SE) — SEK 484 million
Divestment of BioPhausia AB (SE) to Karo Pharma AB (SE) by Medivir AB (SE) — Enterprice value SEK 908 million Healthcare Divestment of BioPhausia AB (SE) to Karo Pharma AB (SE) by Medivir AB (SE) — Enterprice value SEK 908 million
Initial public offering of Ahlsell AB (SE) on Nasdaq Stockholm – SEK 6.9 billion Industrials Initial public offering of Ahlsell AB (SE) on Nasdaq Stockholm – SEK 6.9 billion
Placing of shares in Dustin Group AB (SE) — SEK 351 million TMT Placing of shares in Dustin Group AB (SE) — SEK 351 million
Directed new share issue in Hansa Medical AB (SE) — SEK 185 million Healthcare Directed new share issue in Hansa Medical AB (SE) — SEK 185 million
Rights issue in PledPharma (SE) — SEK 406 million Healthcare Rights issue in PledPharma (SE) — SEK 406 million
Directed new share issue in Starbreeze AB (SE) — SEK 385 million TMT Directed new share issue in Starbreeze AB (SE) — SEK 385 million
Divestment of Bygghemma Group Nordic AB (SE) to FSN Captial IV & V (SE) by Nordstjernan (SE) — Amount not disclosed Consumer & Retail Divestment of Bygghemma Group Nordic AB (SE) to FSN Captial IV & V (SE) by Nordstjernan (SE) — Amount not disclosed
Acquisition of Plantasjen (NO) by Ratos (SE) — NOK 2.9 billion Consumer & Retail Acquisition of Plantasjen (NO) by Ratos (SE) — NOK 2.9 billion
Preference share issue in K2A Knaust & Andersson Fastigheter AB (SE) — SEK 108 million Real Estate Preference share issue in K2A Knaust & Andersson Fastigheter AB (SE) — SEK 108 million